Virtual Presentation

Evolving Options and Challenges in Mantle Cell Lymphoma

Source: Spanning the Spectrum of Care: Clinical Advances and Practical Applications in Lymphoma

Evolving Options and Challenges in Mantle Cell Lymphoma

Faculty:

Andre Goy, MD, MPH

CREDIT INFORMATION

Release Date: 05/21/09

Expiration Date: 05/20/10

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss new data on the role of frontline intensive therapeutic strategies for the treatment of mantle cell lymphoma
Cite recent clinical trial results on the use of new agents for previously untreated and relapsed/refractory mantle cell lymphoma
Summarize recent data on the value of biomarkers and disease-related factors in predicting patient outcomes

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.